Drug Trial Radar · NCT07492316
RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
24
Planned (sponsor's estimate)
Start
Apr 24, 2026
Primary completion
Sep 1, 2030
Study completion Mar 31, 2031
Sponsor
- Lead sponsor
- University of FloridaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Pediatric Neuro-Oncology Consortium
- First posted
- Mar 25, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years, up to 39 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in pediatric patients with recurrent/progressive Medulloblastoma (MB)
Conditions
- Recurrent Medulloblastoma
Interventions
Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)Biological
RNA-LP vaccines will be administered intravenous. Three RNA-LP vaccines will be administered every 2 weeks followed by 12 cycles of adjuvant monthly RNA-LP vaccines for a total of 15 vaccines.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Manufacturing feasibilityTime frame: from the date of surgery until administration of third vaccine, up to 15 weeks
- Safety of RNA-LP vaccineTime frame: First vaccine through 14 days after administration of the 3rd vaccine
- Determination of Maximum Tolerated DoseTime frame: up to 60 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Children's National Hospital
Washington D.C., District of Columbia · Recruiting
UF Health Shands Children's Hospital
Gainesville, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.